Cargando…
Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial
BACKGROUND: Patients with dilated cardiomyopathy whose symptoms and cardiac function have recovered often ask whether their medications can be stopped. The safety of withdrawing treatment in this situation is unknown. METHODS: We did an open-label, pilot, randomised trial to examine the effect of ph...
Autores principales: | Halliday, Brian P, Wassall, Rebecca, Lota, Amrit S, Khalique, Zohya, Gregson, John, Newsome, Simon, Jackson, Robert, Rahneva, Tsveta, Wage, Rick, Smith, Gillian, Venneri, Lucia, Tayal, Upasana, Auger, Dominique, Midwinter, William, Whiffin, Nicola, Rajani, Ronak, Dungu, Jason N, Pantazis, Antonis, Cook, Stuart A, Ware, James S, Baksi, A John, Pennell, Dudley J, Rosen, Stuart D, Cowie, Martin R, Cleland, John G F, Prasad, Sanjay K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319251/ https://www.ncbi.nlm.nih.gov/pubmed/30429050 http://dx.doi.org/10.1016/S0140-6736(18)32484-X |
Ejemplares similares
-
Heart Rate as a Marker of Relapse During Withdrawal of Therapy in Recovered Dilated Cardiomyopathy
por: Halliday, Brian P., et al.
Publicado: (2021) -
Changes in clinical and imaging variables during withdrawal of heart failure therapy in recovered dilated cardiomyopathy
por: Halliday, Brian P., et al.
Publicado: (2022) -
Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction
por: Halliday, Brian P., et al.
Publicado: (2017) -
A qualitative exploration of participant and investigator perspectives from the TRED‐HF trial
por: Papageorgiou, Vasiliki, et al.
Publicado: (2021) -
Phenotype and Clinical Outcomes of Titin Cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2017)